Relationship between growth hormone 1 genetic polymorphism and susceptibility to colorectal cancer. 2010

Chang-Ming Gao, and Jian-Ping Gong, and Jian-Zhong Wu, and Hai-Xia Cao, and Jian-Hua Ding, and Jian-Nong Zhou, and Yan-Ting Liu, and Su-Ping Li, and Jia Cao, and Keitaro Matsuo, and Toshiro Takezaki, and Kazuo Tajima
Division of Epidemiology, Jiangsu Provincial Institute of Cancer Research, Nanjing, Jiangsu Province, China. gaocm888@126.com

The aim of this study was to evaluate the relationship between smoking, alcohol drinking and genetic polymorphism of the growth hormone 1 gene (GH1) T1663A with reference to colorectal cancer. We conducted a case-control study with 315 cases of colorectal cancer and 438 population-based controls in the Jiangsu Province, China. GH1 T1663A genotypes were identified using PCR-RFLP (restriction fragment length polymorphism) methods. Information on smoking and drinking was collected using a questionnaire. Odds ratios (ORs) were estimated with an unconditional logistic model. The distribution of T/T and A/A genotypes was significantly different between controls and cases (chi(2)(MH)=3.877, P=0.049). Compared with the GH1 T/T genotype, the A/A genotype was at a decreased risk of developing colorectal cancer (sex-, age-, body mass index-, smoking- and alcohol drinking-adjusted OR=0.56, 95% confidence interval: 0.34-0.90). Smoking was not associated with the risk of colorectal cancer, whereas alcohol drinking was associated with an increased risk of colorectal cancer. Among nonsmokers or nondrinkers, individuals who had the GH1 A/A genotype were at a decreased risk of developing colorectal cancer compared with individuals who had the GH1 T allele. These results show that the GH1 T1663A A/A genotype can decrease the risk for colorectal cancer.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D016017 Odds Ratio The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases. Cross-Product Ratio,Risk Ratio,Relative Odds,Cross Product Ratio,Cross-Product Ratios,Odds Ratios,Odds, Relative,Ratio, Cross-Product,Ratio, Risk,Ratios, Cross-Product,Ratios, Risk,Risk Ratios

Related Publications

Chang-Ming Gao, and Jian-Ping Gong, and Jian-Zhong Wu, and Hai-Xia Cao, and Jian-Hua Ding, and Jian-Nong Zhou, and Yan-Ting Liu, and Su-Ping Li, and Jia Cao, and Keitaro Matsuo, and Toshiro Takezaki, and Kazuo Tajima
November 2010, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
Chang-Ming Gao, and Jian-Ping Gong, and Jian-Zhong Wu, and Hai-Xia Cao, and Jian-Hua Ding, and Jian-Nong Zhou, and Yan-Ting Liu, and Su-Ping Li, and Jia Cao, and Keitaro Matsuo, and Toshiro Takezaki, and Kazuo Tajima
October 2011, Molecular biology reports,
Chang-Ming Gao, and Jian-Ping Gong, and Jian-Zhong Wu, and Hai-Xia Cao, and Jian-Hua Ding, and Jian-Nong Zhou, and Yan-Ting Liu, and Su-Ping Li, and Jia Cao, and Keitaro Matsuo, and Toshiro Takezaki, and Kazuo Tajima
May 2004, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Chang-Ming Gao, and Jian-Ping Gong, and Jian-Zhong Wu, and Hai-Xia Cao, and Jian-Hua Ding, and Jian-Nong Zhou, and Yan-Ting Liu, and Su-Ping Li, and Jia Cao, and Keitaro Matsuo, and Toshiro Takezaki, and Kazuo Tajima
December 2004, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
Chang-Ming Gao, and Jian-Ping Gong, and Jian-Zhong Wu, and Hai-Xia Cao, and Jian-Hua Ding, and Jian-Nong Zhou, and Yan-Ting Liu, and Su-Ping Li, and Jia Cao, and Keitaro Matsuo, and Toshiro Takezaki, and Kazuo Tajima
April 2004, Zhongguo fei ai za zhi = Chinese journal of lung cancer,
Chang-Ming Gao, and Jian-Ping Gong, and Jian-Zhong Wu, and Hai-Xia Cao, and Jian-Hua Ding, and Jian-Nong Zhou, and Yan-Ting Liu, and Su-Ping Li, and Jia Cao, and Keitaro Matsuo, and Toshiro Takezaki, and Kazuo Tajima
September 1993, Carcinogenesis,
Chang-Ming Gao, and Jian-Ping Gong, and Jian-Zhong Wu, and Hai-Xia Cao, and Jian-Hua Ding, and Jian-Nong Zhou, and Yan-Ting Liu, and Su-Ping Li, and Jia Cao, and Keitaro Matsuo, and Toshiro Takezaki, and Kazuo Tajima
November 2013, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Chang-Ming Gao, and Jian-Ping Gong, and Jian-Zhong Wu, and Hai-Xia Cao, and Jian-Hua Ding, and Jian-Nong Zhou, and Yan-Ting Liu, and Su-Ping Li, and Jia Cao, and Keitaro Matsuo, and Toshiro Takezaki, and Kazuo Tajima
April 2019, Immunological investigations,
Chang-Ming Gao, and Jian-Ping Gong, and Jian-Zhong Wu, and Hai-Xia Cao, and Jian-Hua Ding, and Jian-Nong Zhou, and Yan-Ting Liu, and Su-Ping Li, and Jia Cao, and Keitaro Matsuo, and Toshiro Takezaki, and Kazuo Tajima
November 2015, Genetics and molecular research : GMR,
Chang-Ming Gao, and Jian-Ping Gong, and Jian-Zhong Wu, and Hai-Xia Cao, and Jian-Hua Ding, and Jian-Nong Zhou, and Yan-Ting Liu, and Su-Ping Li, and Jia Cao, and Keitaro Matsuo, and Toshiro Takezaki, and Kazuo Tajima
January 2012, Medicina (Kaunas, Lithuania),
Copied contents to your clipboard!